CRF type 2 receptors mediate the metabolic effects of ghrelin in C2C12 cells

Obesity

Volumn 22, Issue 2, 2014, Pages 380-389

  Gershon, Eran ^a,b   Vale, Wylie W ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b VOLCANI CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; ANTIBODIES, BLOCKING; BIOLOGICAL TRANSPORT; CELL LINE; CELL MEMBRANE; GENE EXPRESSION REGULATION; GHRELIN; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; ION CHANNELS; MICE; MITOCHONDRIAL PROTEINS; MYOBLASTS; PROTEIN TRANSPORT; PYRIMIDINES; PYRROLES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, GHRELIN; RETINOL-BINDING PROTEINS, PLASMA; SIGNAL TRANSDUCTION; UROCORTINS;

EID: 84895908314     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20535     Document Type: Article

References (40)

1. Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660.
2. Hosoda H, Kojima M, Kangawa K,. Biological, physiological, and pharmacological aspects of ghrelin. J Pharmacol Sci 2006; 100: 398-410.
3. Barazzoni R, Bosutti A, Stebel M, et al. Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle. Am J Physiol Endocrinol Metab 2005; 288: E228-E235.
4. Barazzoni R, Zanetti M, Cattin MR, et al. Ghrelin enhances in vivo skeletal muscle but not liver AKT signaling in rats. Obesity (Silver Spring) 2007; 15: 2614-2623.
5. Delhanty PJ, Sun Y, Visser JA, et al. Unacylated ghrelin rapidly modulates lipogenic and insulin signaling pathway gene expression in metabolically active tissues of GHSR deleted mice. PLoS One 2010; 5: e11749.
6. Heijboer AC, van den Hoek AM, Parlevliet ET, et al. Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice. Diabetologia 2006; 49: 732-738.
7. Meier U, Gressner AM,. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004; 50: 1511-1525.
8. Vestergaard ET, Buhl M, Gjedsted J, et al. Acute peripheral metabolic effects of intraarterial ghrelin infusion in healthy young men. J Clin Endocrinol Metab 2011; 96: 468-477.
9. Vestergaard ET, Djurhuus CB, Gjedsted J, et al. Acute effects of ghrelin administration on glucose and lipid metabolism. J Clin Endocrinol Metab 2008; 93: 438-444.
10. Vale W, Spiess J, Rivier C, Rivier J,. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981; 213: 1394-1397.
11. Chen R, Lewis KA, Perrin MH, et al. Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 1993; 90: 8967-8971.
12. Lovenberg TW, Liaw CW, Grigoriadis DE, et al. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 1995; 92: 836-840.
13. Perrin M, Donaldson C, Chen R, et al. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci USA 1995; 92: 2969-2973.
14. Kishimoto T, Pearse RV, 2nd, Lin CR, Rosenfeld MG,. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 1995; 92: 1108-1112.
15. Kostich WA, Chen A, Sperle K, Largent BL,. Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor. Mol Endocrinol 1998; 12: 1077-1085.
16. Liaw CW, Lovenberg TW, Barry G, et al. Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid. Endocrinology 1996; 137: 72-77.
17. Stenzel P, Kesterson R, Yeung W, et al. Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. Mol Endocrinol 1995; 9: 637-645.
18. Chen A, Brar B, Choi CS, et al. Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle. Proc Natl Acad Sci USA 2006; 103: 16580-16585.
19. Tabarin A, Diz-Chaves Y, Consoli D, et al. Role of the corticotropin-releasing factor receptor type 2 in the control of food intake in mice: a meal pattern analysis. Eur J Neurosci 2007; 26: 2303-2314.
20. Chen CY, Inui A, Asakawa A, et al. Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology 2005; 129: 8-25.
21. Tebbe JJ, Mronga S, Tebbe CG, et al. Ghrelin-induced stimulation of colonic propulsion is dependent on hypothalamic neuropeptide Y1- and corticotrophin-releasing factor 1 receptor activation. J Neuroendocrinol 2005; 17: 570-576.
22. Kageyama K, et al. Ghrelin stimulates corticotropin-releasing factor and vasopressin gene expression in rat hypothalamic 4B cells. Stress 2011; 14: 520-529.
23. Johnstone LE, Srisawat R, Kumarnsit E, et al. Hypothalamic expression of NPY mRNA, vasopressin mRNA and CRF mRNA in response to food restriction and central administration of the orexigenic peptide GHRP-6. Stress 2005; 8: 59-67.
24. Asakawa A, Inui A, Kaga T, et al. A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology 2001; 74: 143-147.
25. Kodomari I, Maruoka T, Yamauchi R, et al. Ghrelin alters postnatal endocrine secretion and behavior in mouse offspring. Neurochem Int 2009; 54: 222-228.
26. Filigheddu N, Gnocchi VF, Coscia M, et al. Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. Mol Biol Cell 2007; 18: 986-994.
27. Kuperman Y, Issler O, Vaughan J, et al. Expression and regulation of corticotropin-releasing factor receptor type 2beta in developing and mature mouse skeletal muscle. Mol Endocrinol 2011; 25: 157-169.
28. Yamamoto D, Ikeshita N, Matsubara T, et al. GHRP-2, a GHS-R agonist, directly acts on myocytes to attenuate the dexamethasone-induced expressions of muscle-specific ubiquitin ligases, Atrogin-1 and MuRF1. Life Sci 2008; 82: 460-466.
29. Lear PV, Iglesias MJ, Feijoo-Bandin S, et al. Des-acyl ghrelin has specific binding sites and different metabolic effects from ghrelin in cardiomyocytes. Endocrinology 2010; 151: 3286-3298.
30. Tsubone T, Masaki T, Katsuragi I, et al. Ghrelin regulates adiposity in white adipose tissue and UCP1 mRNA expression in brown adipose tissue in mice. Regul Pept 2005; 130: 97-103.
31. Sun Y, Asnicar M, Saha PK, et al. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 2006; 3: 379-386.
32. Andrews ZB, Erion DM, Beiler R, et al. Uncoupling protein-2 decreases the lipogenic actions of ghrelin. Endocrinology 2010; 151: 2078-2086.
33. Lee JH, Tachibana H, Morinaga Y, et al. Modulation of proliferation and differentiation of C2C12 skeletal muscle cells by fatty acids. Life Sci 2009; 84: 415-420.
34. Yin C, Long Q, Lei T, et al. Lipid accumulation mediated by adiponectin in C2C12 myogenesis. BMB Rep 2009; 42: 667-672.
35. Krsek M, Rosicka M, Papezova H, et al. Plasma ghrelin levels and malnutrition: a comparison of two etiologies. Eat Weight Disord 2003; 8: 207-211.
36. Bizzarri C, et al. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children. Eur J Endocrinol 2010; 162: 499-505.
37. Cummings DE, Clement K, Purnell JQ, et al. Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med 2002; 8: 643-644.
38. Goldstone AP, Patterson M, Kalingag N, et al. Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma. J Clin Endocrinol Metab 2005; 90: 2681-2690.
39. Karczewska-Kupczewska M, Straczkowski M, Adamska A, et al. Increased suppression of serum ghrelin concentration by hyperinsulinemia in women with anorexia nervosa. Eur J Endocrinol 2010; 162: 235-239.
40. Kojima M, Hosoda H, Kangawa K,. Clinical endocrinology and metabolism. Ghrelin, a novel growth-hormone-releasing and appetite-stimulating peptide from stomach. Best Pract Res Clin Endocrinol Metab 2004; 18: 517-530.